| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spermatogonia | 30 | 2022 | 155 | 6.960 |
Why?
|
| Andrology | 5 | 2022 | 11 | 4.110 |
Why?
|
| Sertoli Cells | 13 | 2022 | 150 | 3.990 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 11 | 2019 | 47 | 3.200 |
Why?
|
| Stem Cells | 21 | 2019 | 1213 | 3.070 |
Why?
|
| Thyroid Neoplasms | 12 | 2023 | 1866 | 1.990 |
Why?
|
| Spermatogenesis | 12 | 2017 | 308 | 1.600 |
Why?
|
| Stem Cell Niche | 6 | 2022 | 94 | 1.510 |
Why?
|
| Awards and Prizes | 2 | 2022 | 98 | 1.510 |
Why?
|
| Testis | 14 | 2016 | 717 | 1.410 |
Why?
|
| Proto-Oncogene Proteins B-raf | 8 | 2023 | 1283 | 1.410 |
Why?
|
| Cell Differentiation | 12 | 2022 | 4078 | 1.270 |
Why?
|
| Signal Transduction | 14 | 2019 | 11965 | 1.180 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 7 | 2023 | 259 | 1.120 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2019 | 1498 | 1.110 |
Why?
|
| Receptor, Notch1 | 3 | 2013 | 218 | 1.060 |
Why?
|
| CRISPR-Cas Systems | 2 | 2023 | 323 | 0.870 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 2 | 2019 | 18 | 0.810 |
Why?
|
| Gene Editing | 1 | 2023 | 216 | 0.770 |
Why?
|
| Germ Cells | 5 | 2013 | 335 | 0.760 |
Why?
|
| Receptors, Notch | 3 | 2019 | 383 | 0.760 |
Why?
|
| Jagged-1 Protein | 2 | 2019 | 101 | 0.750 |
Why?
|
| Genital Diseases, Male | 1 | 2020 | 27 | 0.740 |
Why?
|
| Nanostructures | 2 | 2014 | 94 | 0.700 |
Why?
|
| Cell Self Renewal | 1 | 2019 | 62 | 0.670 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 127 | 0.630 |
Why?
|
| MAP Kinase Signaling System | 2 | 2023 | 848 | 0.590 |
Why?
|
| DNA-Binding Proteins | 8 | 2018 | 4821 | 0.570 |
Why?
|
| Transcription Factors | 9 | 2018 | 5270 | 0.560 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 20 | 0.510 |
Why?
|
| Animals | 43 | 2023 | 59536 | 0.510 |
Why?
|
| Cellular Microenvironment | 1 | 2014 | 41 | 0.510 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.500 |
Why?
|
| Mutation, Missense | 1 | 2020 | 1152 | 0.500 |
Why?
|
| Silver | 2 | 2014 | 34 | 0.490 |
Why?
|
| Mice | 32 | 2023 | 34495 | 0.480 |
Why?
|
| Regenerative Medicine | 1 | 2014 | 49 | 0.460 |
Why?
|
| Oncogenes | 2 | 2015 | 673 | 0.440 |
Why?
|
| Adult Stem Cells | 1 | 2013 | 73 | 0.440 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2012 | 5 | 0.430 |
Why?
|
| Thyroid Gland | 1 | 2015 | 355 | 0.430 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 460 | 0.430 |
Why?
|
| Carcinoma, Papillary | 1 | 2016 | 584 | 0.430 |
Why?
|
| Metal Nanoparticles | 2 | 2014 | 164 | 0.420 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2012 | 107 | 0.420 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.410 |
Why?
|
| Cell Separation | 2 | 2012 | 612 | 0.410 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.410 |
Why?
|
| Male | 47 | 2022 | 123000 | 0.400 |
Why?
|
| Indoles | 1 | 2016 | 1009 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2010 | 31 | 0.370 |
Why?
|
| Cell Proliferation | 10 | 2021 | 7226 | 0.370 |
Why?
|
| Cell Cycle | 3 | 2016 | 2084 | 0.360 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 694 | 0.350 |
Why?
|
| Genes, Reporter | 1 | 2012 | 798 | 0.350 |
Why?
|
| Pluripotent Stem Cells | 2 | 2009 | 123 | 0.350 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1331 | 0.350 |
Why?
|
| Phthalic Acids | 1 | 2009 | 10 | 0.350 |
Why?
|
| Hazardous Substances | 1 | 2009 | 27 | 0.340 |
Why?
|
| Chemokines | 1 | 2010 | 314 | 0.340 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 1879 | 0.330 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2015 | 716 | 0.330 |
Why?
|
| Antigens, Viral, Tumor | 2 | 2005 | 47 | 0.320 |
Why?
|
| Mice, Knockout | 9 | 2023 | 5710 | 0.300 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 3343 | 0.300 |
Why?
|
| Sulfonamides | 1 | 2016 | 1823 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8873 | 0.290 |
Why?
|
| Antineoplastic Agents | 5 | 2022 | 14289 | 0.290 |
Why?
|
| Cell Line | 7 | 2012 | 5114 | 0.290 |
Why?
|
| Mammals | 1 | 2008 | 361 | 0.280 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 8 | 2012 | 26 | 0.280 |
Why?
|
| Immunohistochemistry | 9 | 2018 | 7548 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-ret | 5 | 2010 | 370 | 0.280 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 2359 | 0.270 |
Why?
|
| Mutation | 4 | 2021 | 15179 | 0.270 |
Why?
|
| Nerve Growth Factors | 2 | 2007 | 109 | 0.270 |
Why?
|
| Cell Transformation, Viral | 1 | 2005 | 138 | 0.250 |
Why?
|
| Nanotechnology | 1 | 2005 | 137 | 0.250 |
Why?
|
| RNA Interference | 4 | 2016 | 1408 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 3101 | 0.250 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2023 | 4757 | 0.240 |
Why?
|
| Iodine Radioisotopes | 2 | 2023 | 371 | 0.240 |
Why?
|
| src-Family Kinases | 1 | 2006 | 478 | 0.240 |
Why?
|
| Recombinases | 1 | 2023 | 29 | 0.230 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2016 | 5178 | 0.220 |
Why?
|
| Phenotype | 4 | 2023 | 6295 | 0.220 |
Why?
|
| Semen Analysis | 1 | 2022 | 32 | 0.220 |
Why?
|
| Fertilization | 1 | 2022 | 56 | 0.220 |
Why?
|
| Humanities | 1 | 2022 | 17 | 0.220 |
Why?
|
| Semen | 1 | 2022 | 90 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 7 | 2016 | 2314 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2006 | 810 | 0.210 |
Why?
|
| Growth Substances | 1 | 2003 | 300 | 0.210 |
Why?
|
| Bibliometrics | 1 | 2022 | 71 | 0.210 |
Why?
|
| Introns | 1 | 2023 | 432 | 0.210 |
Why?
|
| Editorial Policies | 1 | 2022 | 87 | 0.210 |
Why?
|
| Humans | 26 | 2023 | 261506 | 0.200 |
Why?
|
| Blotting, Western | 5 | 2012 | 3536 | 0.200 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2005 | 661 | 0.200 |
Why?
|
| Biomarkers, Tumor | 3 | 2021 | 10331 | 0.200 |
Why?
|
| Cells, Cultured | 5 | 2017 | 5637 | 0.180 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 216 | 0.180 |
Why?
|
| Membrane Proteins | 3 | 2009 | 2819 | 0.180 |
Why?
|
| Liquid Biopsy | 1 | 2020 | 158 | 0.170 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2019 | 39 | 0.170 |
Why?
|
| Cell Communication | 1 | 2022 | 509 | 0.170 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 2045 | 0.170 |
Why?
|
| Blood-Testis Barrier | 2 | 2009 | 6 | 0.170 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 406 | 0.170 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2021 | 224 | 0.160 |
Why?
|
| Genetic Engineering | 1 | 2020 | 288 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 3639 | 0.160 |
Why?
|
| Cell Culture Techniques | 2 | 2013 | 598 | 0.160 |
Why?
|
| Protein Kinases | 1 | 2022 | 874 | 0.160 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 4143 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 1491 | 0.160 |
Why?
|
| SOX9 Transcription Factor | 1 | 2019 | 170 | 0.160 |
Why?
|
| Data Collection | 1 | 2020 | 620 | 0.150 |
Why?
|
| Cell Movement | 2 | 2018 | 2466 | 0.150 |
Why?
|
| Transcription Factor HES-1 | 1 | 2017 | 49 | 0.150 |
Why?
|
| Genes, ras | 1 | 2020 | 667 | 0.150 |
Why?
|
| Cell Survival | 3 | 2012 | 3045 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 2488 | 0.140 |
Why?
|
| Feedback, Physiological | 1 | 2017 | 193 | 0.140 |
Why?
|
| Benzhydryl Compounds | 1 | 2016 | 85 | 0.140 |
Why?
|
| Cyclic AMP | 1 | 2017 | 358 | 0.140 |
Why?
|
| Phenols | 1 | 2016 | 107 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 639 | 0.140 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 14551 | 0.130 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2016 | 160 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 259 | 0.130 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2016 | 146 | 0.130 |
Why?
|
| Gain of Function Mutation | 1 | 2016 | 126 | 0.130 |
Why?
|
| Apoptosis | 5 | 2021 | 7591 | 0.130 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2015 | 142 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 280 | 0.130 |
Why?
|
| Sex Factors | 1 | 2020 | 2139 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 2216 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2012 | 4804 | 0.120 |
Why?
|
| Tissue Engineering | 2 | 2014 | 269 | 0.120 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2020 | 833 | 0.120 |
Why?
|
| Cell Lineage | 2 | 2015 | 668 | 0.120 |
Why?
|
| Calcitonin | 1 | 2015 | 186 | 0.120 |
Why?
|
| Cell Tracking | 1 | 2014 | 38 | 0.120 |
Why?
|
| Pyridones | 1 | 2016 | 348 | 0.120 |
Why?
|
| Animals, Newborn | 4 | 2009 | 1338 | 0.110 |
Why?
|
| Nervous System Neoplasms | 1 | 2013 | 36 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1077 | 0.110 |
Why?
|
| Equidae | 1 | 2012 | 1 | 0.110 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2013 | 44 | 0.110 |
Why?
|
| Benzimidazoles | 1 | 2016 | 428 | 0.110 |
Why?
|
| Biomarkers | 2 | 2018 | 5047 | 0.110 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2015 | 223 | 0.110 |
Why?
|
| Aging | 2 | 2013 | 1582 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 973 | 0.110 |
Why?
|
| Seminiferous Tubules | 3 | 2012 | 52 | 0.110 |
Why?
|
| Tissue Scaffolds | 1 | 2014 | 135 | 0.110 |
Why?
|
| Gene Expression | 4 | 2014 | 3570 | 0.110 |
Why?
|
| Hydrogels | 1 | 2013 | 123 | 0.110 |
Why?
|
| Staining and Labeling | 1 | 2014 | 429 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 419 | 0.110 |
Why?
|
| Bone Diseases | 1 | 2013 | 143 | 0.100 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2013 | 200 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 7222 | 0.100 |
Why?
|
| Integrases | 1 | 2013 | 262 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2013 | 699 | 0.100 |
Why?
|
| Receptors, CCR1 | 1 | 2010 | 4 | 0.100 |
Why?
|
| Chemokine CCL7 | 1 | 2010 | 12 | 0.100 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2010 | 17 | 0.100 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2010 | 34 | 0.100 |
Why?
|
| Chemokine CXCL5 | 1 | 2010 | 13 | 0.100 |
Why?
|
| Paraganglioma | 1 | 2013 | 170 | 0.100 |
Why?
|
| Chemokines, CC | 1 | 2010 | 36 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1217 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.100 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 191 | 0.090 |
Why?
|
| Immunotherapy | 2 | 2023 | 3341 | 0.090 |
Why?
|
| Mitosis | 1 | 2013 | 615 | 0.090 |
Why?
|
| Pheochromocytoma | 1 | 2013 | 281 | 0.090 |
Why?
|
| Materials Testing | 1 | 2010 | 116 | 0.090 |
Why?
|
| Neoadjuvant Therapy | 2 | 2020 | 4975 | 0.090 |
Why?
|
| Seminiferous Epithelium | 1 | 2009 | 5 | 0.090 |
Why?
|
| Germ Layers | 1 | 2009 | 15 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2012 | 479 | 0.090 |
Why?
|
| Gonads | 1 | 2009 | 53 | 0.090 |
Why?
|
| Fetus | 1 | 2013 | 601 | 0.090 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2009 | 31 | 0.080 |
Why?
|
| Testosterone | 1 | 2014 | 619 | 0.080 |
Why?
|
| Colony-Forming Units Assay | 1 | 2009 | 249 | 0.080 |
Why?
|
| Disease Progression | 1 | 2020 | 6682 | 0.080 |
Why?
|
| Spermatozoa | 2 | 2009 | 315 | 0.080 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 1249 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2054 | 0.080 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2013 | 489 | 0.080 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 3 | 2012 | 17 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2016 | 2295 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2007 | 123 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 3203 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 987 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 3251 | 0.070 |
Why?
|
| Cell Division | 2 | 2015 | 2489 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2009 | 429 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2009 | 1008 | 0.070 |
Why?
|
| Cadmium Compounds | 1 | 2005 | 7 | 0.070 |
Why?
|
| Silver Compounds | 1 | 2005 | 6 | 0.070 |
Why?
|
| Carbonates | 1 | 2005 | 12 | 0.070 |
Why?
|
| Phenazines | 1 | 2005 | 13 | 0.070 |
Why?
|
| Molybdenum | 1 | 2005 | 19 | 0.070 |
Why?
|
| Tetrazolium Salts | 1 | 2005 | 54 | 0.070 |
Why?
|
| Microscopy, Electron | 2 | 2003 | 600 | 0.070 |
Why?
|
| Middle Aged | 7 | 2021 | 86204 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2012 | 3033 | 0.060 |
Why?
|
| Fertility | 1 | 2007 | 336 | 0.060 |
Why?
|
| Oxides | 1 | 2005 | 211 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 7789 | 0.060 |
Why?
|
| Simian virus 40 | 1 | 2005 | 137 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2009 | 554 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2005 | 299 | 0.060 |
Why?
|
| Protein Binding | 1 | 2010 | 3438 | 0.060 |
Why?
|
| Carcinoma | 1 | 2015 | 2578 | 0.060 |
Why?
|
| Aged | 6 | 2021 | 70117 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2016 | 3518 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3230 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2005 | 621 | 0.060 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2023 | 67 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 4938 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 5159 | 0.060 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2003 | 25 | 0.060 |
Why?
|
| ras Proteins | 1 | 2007 | 770 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2007 | 677 | 0.060 |
Why?
|
| Fibronectins | 1 | 2023 | 197 | 0.060 |
Why?
|
| Body Weight | 1 | 2007 | 1293 | 0.060 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2003 | 110 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 6942 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 394 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2003 | 207 | 0.050 |
Why?
|
| Peer Review | 1 | 2022 | 80 | 0.050 |
Why?
|
| Carcinogenicity Tests | 1 | 2021 | 70 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2023 | 587 | 0.050 |
Why?
|
| Female | 10 | 2021 | 141928 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2003 | 626 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 5539 | 0.050 |
Why?
|
| Thiazoles | 1 | 2005 | 726 | 0.050 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2012 | 72 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2021 | 126 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 2576 | 0.050 |
Why?
|
| Publishing | 1 | 2022 | 220 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3821 | 0.050 |
Why?
|
| Blastocyst | 1 | 2020 | 124 | 0.050 |
Why?
|
| RNA, Messenger | 4 | 2014 | 6150 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 1360 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2021 | 521 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2020 | 32848 | 0.040 |
Why?
|
| Mitochondria | 1 | 2005 | 1282 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 29902 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 9244 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 4053 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2010 | 2508 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2020 | 486 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 3154 | 0.040 |
Why?
|
| Mitotane | 1 | 2015 | 39 | 0.030 |
Why?
|
| Toxicity Tests, Subacute | 1 | 2014 | 4 | 0.030 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2014 | 7 | 0.030 |
Why?
|
| Progesterone Reductase | 1 | 2014 | 6 | 0.030 |
Why?
|
| Steroid Isomerases | 1 | 2014 | 13 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 5395 | 0.030 |
Why?
|
| Prognosis | 2 | 2021 | 21713 | 0.030 |
Why?
|
| Anilides | 1 | 2015 | 268 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 2014 | 213 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2014 | 249 | 0.030 |
Why?
|
| Artiodactyla | 1 | 2012 | 2 | 0.030 |
Why?
|
| Leydig Cells | 1 | 2012 | 39 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2023 | 37905 | 0.030 |
Why?
|
| DNA Replication | 1 | 2016 | 744 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 6009 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 159 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 2291 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 202 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 4988 | 0.030 |
Why?
|
| Spinal Cord Compression | 1 | 2013 | 151 | 0.030 |
Why?
|
| Adult | 4 | 2021 | 77950 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 2864 | 0.020 |
Why?
|
| Selenoprotein P | 1 | 2010 | 3 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 270 | 0.020 |
Why?
|
| Immunomagnetic Separation | 1 | 2010 | 43 | 0.020 |
Why?
|
| Adenoma | 1 | 2015 | 716 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2013 | 291 | 0.020 |
Why?
|
| Claudin-5 | 1 | 2009 | 5 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 221 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 9180 | 0.020 |
Why?
|
| Chronic Pain | 1 | 2013 | 238 | 0.020 |
Why?
|
| Microdissection | 1 | 2009 | 86 | 0.020 |
Why?
|
| Models, Biological | 2 | 2008 | 3254 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 508 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 3552 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2009 | 223 | 0.020 |
Why?
|
| Cell Transdifferentiation | 1 | 2009 | 112 | 0.020 |
Why?
|
| Young Adult | 2 | 2020 | 21445 | 0.020 |
Why?
|
| Pyridines | 1 | 2015 | 1244 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 10001 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 1954 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 1547 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12221 | 0.020 |
Why?
|
| Cisplatin | 1 | 2015 | 2432 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 12873 | 0.020 |
Why?
|
| Growth and Development | 1 | 2007 | 28 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2010 | 382 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 4307 | 0.020 |
Why?
|
| Tight Junctions | 1 | 2007 | 56 | 0.020 |
Why?
|
| Spermatids | 1 | 2007 | 42 | 0.020 |
Why?
|
| Spermatocytes | 1 | 2007 | 43 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1859 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 769 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 591 | 0.020 |
Why?
|
| Organ Size | 1 | 2007 | 690 | 0.020 |
Why?
|
| United States | 1 | 2023 | 15433 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 671 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 1062 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2330 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 1013 | 0.020 |
Why?
|
| Uterus | 1 | 2009 | 678 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 677 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 1242 | 0.010 |
Why?
|
| Prostate | 1 | 2009 | 1088 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 1555 | 0.010 |
Why?
|
| Skin | 1 | 2009 | 1259 | 0.010 |
Why?
|
| Paraffin Embedding | 1 | 2003 | 226 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 4109 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 1442 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 5377 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 1648 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 31252 | 0.010 |
Why?
|
| Child | 1 | 2013 | 29154 | 0.010 |
Why?
|